000911397 001__ 911397
000911397 005__ 20221116131015.0
000911397 0247_ $$2doi$$a10.1101/2022.11.04.22281936
000911397 0247_ $$2Handle$$a2128/32597
000911397 037__ $$aFZJ-2022-04680
000911397 1001_ $$0P:(DE-Juel1)188324$$aSchaare, H. Lina$$b0$$eCorresponding author
000911397 245__ $$aMental health, blood pressure and the development of hypertension
000911397 260__ $$c2022
000911397 3367_ $$0PUB:(DE-HGF)25$$2PUB:(DE-HGF)$$aPreprint$$bpreprint$$mpreprint$$s1668514392_2646
000911397 3367_ $$2ORCID$$aWORKING_PAPER
000911397 3367_ $$028$$2EndNote$$aElectronic Article
000911397 3367_ $$2DRIVER$$apreprint
000911397 3367_ $$2BibTeX$$aARTICLE
000911397 3367_ $$2DataCite$$aOutput Types/Working Paper
000911397 520__ $$aHypertension (HTN) has been associated with a greater risk of affective disorders. Paradoxically, several studies have shown the opposite effect in which high blood pressure relates to less depressive symptoms and greater well-being. Here we dissolve this paradox and clarify the relationship between mental health, blood pressure and the development of HTN using the UK Biobank. In adjusted multiple linear regression models, we found that the presence of a HTN diagnosis was associated with impaired mental health (i.e. more depressive symptoms (N = 303,771; β = 0.043; 95% CI [0.039, 0.047]; p<0.001) and lower well-being scores (N = 129,876; β = -0.057; 95% CI [-0.064, - 0.050]; p<0.001)) at baseline, whereas higher systolic blood pressure (SBP) was associated with fewer depressive symptoms (N = 303,771; β = -0.063; 95% CI [-0.067, -0.060]; p<0.001) and higher well-being scores (N = 129,876; β = 0.057; 95% CI [0.051, 0.063]; p<0.001). These effects persisted until follow-up (∼10 years later). To explore a potential link between the mental health-blood pressure association and the development of HTN, we compared participants who were normotensive at baseline and developed HTN until follow-up with those who stayed normotensive. Notably, the adjusted model showed impaired mental health already at baseline in HTN developers (i.e., before HTN diagnosis; depressive symptoms: β = 0.060; 95% CI [0.045, 0.076]; p<0.001; well-being: β = -0.043; 95% CI [-0.068, -0.017]; p<0.001), indicating that people who develop HTN might require higher blood pressure levels for the same mental health outcomes as normotensives. In addition, the negative association between SBP and depressive symptoms at baseline was moderated by HTN development (β = -0.014; 95% CI [-0.026, -0.003]; p=0.015), suggesting that the negative relationship between mental health and blood pressure was accentuated in people developing HTN several years before receiving their HTN diagnosis. We further observed that higher SBP was associated with lower emotion-related brain activity from functional magnetic resonance imaging (fMRI; β = -0.032 95% CI [-0.045, -0.019]; p<0.001). This effect was also moderated by HTN diagnosis, suggesting an impact of SBP and HTN on the central nervous processing of emotions. Possible mechanisms are discussed, including regulatory baroreceptor circuits linking arterial blood pressure to neural processing of emotions. Overall, our results show an interrelation between mental health and blood pressure that may be involved in the development of HTN. In people who develop HTN, this relationship seems to be altered, such that higher blood pressure is required to sustain mental health, potentially offering a novel perspective for developing preventive and therapeutic measures.
000911397 536__ $$0G:(DE-HGF)POF4-5251$$a5251 - Multilevel Brain Organization and Variability (POF4-525)$$cPOF4-525$$fPOF IV$$x0
000911397 588__ $$aDataset connected to CrossRef
000911397 7001_ $$0P:(DE-HGF)0$$aBlöchl, Maria$$b1
000911397 7001_ $$0P:(DE-HGF)0$$aKumral, Deniz$$b2
000911397 7001_ $$0P:(DE-HGF)0$$aUhlig, Marie$$b3
000911397 7001_ $$0P:(DE-HGF)0$$aLemcke, Lorenz$$b4
000911397 7001_ $$0P:(DE-Juel1)173843$$aValk, Sofie L.$$b5$$ufzj
000911397 7001_ $$0P:(DE-HGF)0$$aVillringer, Arno$$b6
000911397 773__ $$a10.1101/2022.11.04.22281936
000911397 8564_ $$uhttps://www.medrxiv.org/content/10.1101/2022.11.04.22281936v1
000911397 8564_ $$uhttps://juser.fz-juelich.de/record/911397/files/2022.11.04.22281936.full.pdf$$yOpenAccess
000911397 909CO $$ooai:juser.fz-juelich.de:911397$$popenaire$$popen_access$$pVDB$$pdriver$$pdnbdelivery
000911397 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)188324$$aForschungszentrum Jülich$$b0$$kFZJ
000911397 9101_ $$0I:(DE-HGF)0$$6P:(DE-Juel1)188324$$a Max Planck Institute for Human Cognitive and Brain Sciences: Leipzig$$b0
000911397 9101_ $$0I:(DE-HGF)0$$6P:(DE-Juel1)188324$$a HHU Düsseldorf$$b0
000911397 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)173843$$aForschungszentrum Jülich$$b5$$kFZJ
000911397 9101_ $$0I:(DE-HGF)0$$6P:(DE-Juel1)173843$$a Max Planck Institute for Human Cognitive and Brain Sciences: Leipzig$$b5
000911397 9101_ $$0I:(DE-HGF)0$$6P:(DE-Juel1)173843$$a HHU Düsseldorf$$b5
000911397 9131_ $$0G:(DE-HGF)POF4-525$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5251$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vDecoding Brain Organization and Dysfunction$$x0
000911397 9141_ $$y2022
000911397 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000911397 915__ $$0LIC:(DE-HGF)CCBYNC4$$2HGFVOC$$aCreative Commons Attribution-NonCommercial CC BY-NC 4.0
000911397 920__ $$lyes
000911397 9201_ $$0I:(DE-Juel1)INM-7-20090406$$kINM-7$$lGehirn & Verhalten$$x0
000911397 980__ $$apreprint
000911397 980__ $$aVDB
000911397 980__ $$aUNRESTRICTED
000911397 980__ $$aI:(DE-Juel1)INM-7-20090406
000911397 9801_ $$aFullTexts